Senescent Lung Fibroblasts in Idiopathic Pulmonary Fibrosis Facilitate Non-Small Cell Lung Cancer Progression by Secreting Exosomal MMP1

Medicine, Respiratory System, Oncology, Life Sciences, Cell Biology, Immunology,
Idiopathic Pulmonary Fibrosis   Non-Small Cell Lung Cancer   Exosomes   MMP1   PI3K-AKT-mTOR Pathway   Senescence-Associated Secretory Phenotype   Tumor Microenvironment  

Academic Background and Problem Statement Idiopathic Pulmonary Fibrosis (IPF) is a progressive interstitial lung disease associated with aging and is an independent risk factor for lung cancer. Epidemiological studies indicate that 3%-22% of IPF patients develop lung cancer during follow-up, with the cumulative incidence increasing over time, makin...

Efficacy and Safety of Pamrevlumab in Idiopathic Pulmonary Fibrosis: The Zephyrus-1 Randomized Clinical Trial

Medicine, Respiratory System,
Pamrevlumab   Idiopathic Pulmonary Fibrosis   Phase 3 Trial   Lung Function   Antifibrotic Therapy  

Pamrevlumab Treatment for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial Idiopathic Pulmonary Fibrosis (IPF) is a rare interstitial lung disease that typically occurs in adults over 60 years old. It is characterized by cough, breathlessness, and fatigue. This disease leads to progressive loss of lung function, decreased exe...